Cargando…
Randomised controlled trial for high-dose intravenous zinc as adjunctive therapy in SARS-CoV-2 (COVID-19) positive critically ill patients: trial protocol
INTRODUCTION: SARS-CoV-2 (COVID-19) has caused an international pandemic of respiratory illness, resulting in significant healthcare and economic turmoil. To date, no robust vaccine or treatment has been identified. Elemental zinc has previously been demonstrated to have beneficial effects on corona...
Autores principales: | Perera, Marlon, El Khoury, John, Chinni, Vidyasagar, Bolton, Damien, Qu, Liang, Johnson, Paul, Trubiano, Jason, McDonald, Christine F, Jones, Daryl, Bellomo, Rinaldo, Patel, Oneel, Ischia, Joseph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712927/ https://www.ncbi.nlm.nih.gov/pubmed/33268419 http://dx.doi.org/10.1136/bmjopen-2020-040580 |
Ejemplares similares
-
Zinc Preconditioning Provides Cytoprotection following Iodinated Contrast Media Exposure in In Vitro Models
por: Perera, Marlon, et al.
Publicado: (2021) -
Therapies to Prevent Progression of COVID-19, Including Hydroxychloroquine, Azithromycin, Zinc, and Vitamin D3 With or Without Intravenous Vitamin C: An International, Multicenter, Randomized Trial
por: Ried, Karin, et al.
Publicado: (2021) -
Adjunctive clindamycin for cellulitis: a clinical trial comparing flucloxacillin with or without clindamycin for the treatment of limb cellulitis
por: Brindle, Richard, et al.
Publicado: (2017) -
Randomised trial to determine the effect of vitamin D and zinc supplementation for improving treatment outcomes among patients with COVID-19 in India: trial protocol
por: Sharma, Kamal Kant, et al.
Publicado: (2022) -
Artemisinin: A Promising Adjunct for Cancer Therapy
por: Waseem, Yamna, et al.
Publicado: (2018)